Compugen Ltd. (CGEN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Compugen Ltd., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Compugen Ltd. (CGEN) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $186M. It trades at $2.01, up 2.03% today, at 5.4 times earnings. Its overall quality score is 93 out of 100, ranked against the whole US market. 4 analysts' average target of $4.50 implies +123.9% from today's price. Kronos AI's 30-day forecast is +17.9% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $4.50 |
| Low – high | $4.00 – $6.00 |
| Analysts | 4 |
| Upside to average | +123.9% |
Kronos AI 30-day forecast
| Expected close | $2.32 (+17.9%) |
| Likely range | +12.2% … +34.4% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 94 |
| Solvency | 90 |
| Growth | 94 |
| Overall | 93 |
| P/E | 5.4 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator